Surya Bhatt, MD, MSPH
Professor of Medicine
Pulmonary, Allergy & Critical Care Medicine
The University of Alabama at Birmingham
Birmingham, AL

MeiLan King Han, MD, MS
Professor of Medicine
Chief, Division of Pulmonary and Critical Care
University of Michigan Health
Ann Arbor, MI

Christopher L. Mosher, MD, MHS
Assistant Professor of Medicine
Medical Director, Pulmonary Rehabilitation
Division of Pulmonary, Allergy, and Critical Care Medicine
Duke University
Durham, NC

Disclosures:

Conflicts of Interest Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, Horizon CME must ensure balance, independence, objectivity, and scientific rigor. Prior to an activity, all faculty, authors, editors, and planning committee members participating in a Horizon CME activity are required to disclose to attendees any relevant financial interest or other relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. Horizon CME has mitigated any conflicts of interest for this activity.

Disclosure of Unlabeled Use

Horizon CME requires that faculty participating in any continuing medical education (CME) to disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

Faculty Disclosures

Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity.

• Surya Bhatt, MD, MSPH, discloses that he has served on advisory boards or as consultant for Apreo, Boehringer Ingelheim, Chiesi, Genentech, GSK, Merck, Regeneron, Sanofi, and Verona, and has received honoraria from HorizonCME, IntegrityCE, and Medscape. He has received funds paid to his institute for research from Sanofi, Regeneron, Genentech, and Nuvaira during the past 24 months.
• MeiLan King Han, MD, MS, discloses personal fees from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Cipla, Chiesi, Novartis, Pulmonx, Teva, Verona, Merck, Mylan, Sanofi, Roche, DevPro, Aerogen, Polarian, Regeneron, Amgen, Genentech, UpToDate, Altesa Biopharma, Apreo Health, RS Biotherapeutics, Medscape, NACE, MDBriefcase, Integrity and Medwiz. She has received either in kind research support or funds paid to the institution from the NIH, Novartis, Sunovion, Nuvaira, Sanofi, Astrazeneca, Boehringer Ingelheim, Gala Therapeutics, Biodesix, the COPD Foundation and the American Lung Association. She has participated in Data Safety Monitoring Boards for Novartis and Medtronic with funds paid to the institution. She has received stock options from Meissa Vaccines and Altesa Biopharma during the past 24 months.
• Christopher Mosher, MD, MHS, discloses research support from the National Institute on Aging/National Institutes of Health (R03AG082878-01), American Lung Association Early Career Investigator Award, The Lang Family COPD Research Fund, the Patient-Centered Outcomes Research Institute, AstraZeneca. Consulting fees with COPD Foundation, Wellinks, International Consulting Associates, Inc., Guidepoint, Physicians Education Resources, LLC, Horizon CME, and GlaxoSmithKline during the last 24 months..

Planners

Those others involved in the planning of this activity disclosed no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Other Contributors

All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.